Patient Buzz: Pseudofolliculitis Barbae (PFB) in People With Skin of Color | The Expert Weighs In
NBC News was one of the media outlets who covered the Marines’ recent tightening of shaving waivers, which could negatively impact the careers of Marines with pseudofolliculitis barbae (PFB). Under a 2022 policy, Marines with treatment-resistant PFB could receive temporary or permanent shaving waivers. Now, Marines with PFB could be separated from the branch if their PFB does not improve within …
NBC News was one of the media outlets who covered the Marines’ recent tightening of shaving waivers, which could negatively impact the careers of Marines with pseudofolliculitis barbae (PFB). Under a 2022 policy, Marines with treatment-resistant PFB could receive temporary or permanent shaving waivers. Now, Marines with PFB could be separated from the branch if their PFB does not improve within … 
Applying to dermatopathology fellowship stirs a mix of emotions—excitement, uncertainty, maybe even a bit of stress. The process can feel extremely overwhelming because the dermatopathology application process is significantly different from the residency application process. There’s no ERAS. No Match. Just a lot of googling, emailing, and figuring it out as you go.
In this article, we will … 
Welcome to another installment of our popular “From the JDD Podcast Vault” series! This week, we’re unraveling the fascinating story behind itch management with the episode: From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus, hosted by the ever-engaging Dr. Adam Friedman.
We all know that urge—“Just scratch it!” But for countless patients, chronic prurit … 
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced … 
Use of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and isotretinoin.
I interviewed author Travis W. Blalock, MD, FAAD, FACMS, dire … 